Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R43)

The summary for the Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R43) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R43): The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage grant applications to address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is not to duplicate or compete with the private sector but to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems.
Federal Grant Title: Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R43)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-13-345
Type of Funding: Grant
CFDA Numbers: 93.173, 93.350, 93.865
CFDA Descriptions: Research Related to Deafness and Communication Disorders; National Center for Advancing Translational Sciences; Child Health and Human Development Extramural Research
Current Application Deadline: Sep 7, 2016
Original Application Deadline: Sep 7, 2016
Posted Date: Sep 6, 2013
Creation Date: Sep 6, 2013
Archive Date: Oct 8, 2016
Total Program Funding:
Maximum Federal Grant Award: $150,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-13-345.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Tr...
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Centr...
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Mo...
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technolo...
NIDCD Patient-Oriented Research Grant (R21)
Cell Lineage and Developmental Studies in Hearing and Balance
Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com